Posted by yxibow on February 17, 2007, at 3:21:26
In reply to Re: Sanofi-Aventis Progress Report, posted by notfred on February 14, 2007, at 23:39:56
> "Is it true that in a drug trial when it's over you have to give up the med even if it's working?"
>
>
> Sometimes you cannot contine, sometimes you can continue with the drug. If the drug is not going to make it to market you will not be able to continue the drug. Some people stick to doing only late stage testing; drugs are more likely to make it to market if they make it to late stage testing. You may or may not be able to continue the med between the time the study ends and the drug hits the market.
>
> This is all disclosed to study subjects up front.
There is also compassionate / orphan use of continuation, for say late stage oncology medication. So the purpose depends alot. Since cancer medications can have improvement rates as low as 10%, if you are among the lucky who are improving with the medication, there may be something that the drug company can do between itself and the FDA.
poster:yxibow
thread:732825
URL: http://www.dr-bob.org/babble/20070213/msgs/733537.html